🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01225393
Treatments Being Tested
This phase II trial studies aim to evaluate the initial efficacy of lefluno...
Status
Recruiting
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2020-07-01
Trial ID
NCT06540937
Treatments Being Tested
The main objective of this post-authorization safety study is to assess hea...
Status
Completed
Location
Sanofi-Aventis
Start Date
2025-05-05
Trial ID
NCT06714461
Treatments Being Tested
This phase II trial studies how well leflunomide, pomalidomide, and dexamet...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2020-11-24
Trial ID
NCT04508790
Treatments Being Tested
This phase Ib trial tests the safety, side effects, and best dose of leflun...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-05-13
Trial ID
NCT06454383
The purpose of this study is to determine the safety and tolerability of PR...
Status
Completed
Location
Protalex Investigative Site
Start Date
2012-11
Trial ID
NCT01749787
Triple negative breast cancer (TNBC) represents about 15% of breast cancers...
Status
Completed
Location
Mt Sinai Chelesa
Start Date
2019-04-16
Trial ID
NCT03709446
Treatments Being Tested
The objective of the study is to establish a prospective disease registry f...
Status
Recruiting
Location
Seattle Children's Hospital
Start Date
2018-08-01
Trial ID
NCT04725422
This phase I trial studies the side effects of leflunomide in treating pati...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2020-05-12
Trial ID
NCT04212416
Treatments Being Tested
This Phase 3, randomized, open-label, multicenter study in rheumatoid arthr...
Status
Terminated
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00521924